Literature DB >> 9486188

Structure of murine enterokinase (enteropeptidase) and expression in small intestine during development.

X Yuan1, X Zheng, D Lu, D C Rubin, C Y Pung, J E Sadler.   

Abstract

Enterokinase (enteropeptidase) is expressed only in proximal small intestine, where it initiates digestive enzyme activation by converting trypsinogen into trypsin. To investigate this restricted expression pattern, mouse enterokinase cDNA was cloned, and the distribution of enterokinase mRNA and enzymatic activity were determined in adult mice and during gestation. Analysis of enterokinase sequences showed that a mucinlike domain near the NH2 terminus is composed of repeated approximately 15-amino acid Ser/Thr-rich motifs. By Northern blotting and trypsinogen activation assays, enterokinase mRNA and enzymatic activity were undetectable in stomach, abundant in duodenum, and decreased distally until they were undetectable in midjejunum, ileum, and colon. By in situ mRNA hybridization, enterokinase mRNA was localized to the enterocytes throughout the villus. Expression was not observed in goblet cells, Paneth cells, or Brunner's glands. Enterokinase mRNA and enzymatic activity were not detected in the duodenum of fetal mice but were easily detected in the duodenum on postnatal days 2-6. Both enterokinase mRNA and enzymatic activity decreased to very low levels after day 7 but increased after weaning and reached a high level characteristic of adult life by day 60. Therefore, in mice, duodenal enterocytes are the major type of cells expressing enterokinase, which appears to be regulated at the level of mRNA abundance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486188     DOI: 10.1152/ajpgi.1998.274.2.G342

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.

Authors:  Ao Huang; Houmin Zhou; Hongchao Zhao; Yingjun Quan; Bo Feng; Minhua Zheng
Journal:  Cancer Biol Ther       Date:  2013-12-12       Impact factor: 4.742

2.  Specificity of the medaka enteropeptidase serine protease and its usefulness as a biotechnological tool for fusion-protein cleavage.

Authors:  Katsueki Ogiwara; Takayuki Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

3.  Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.

Authors:  Joni M Prasad; Oleg V Gorkun; Harini Raghu; Sherry Thornton; Eric S Mullins; Joseph S Palumbo; Ya-Ping Ko; Magnus Höök; Tovo David; Shaun R Coughlin; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

Review 4.  Membrane-anchored serine proteases in health and disease.

Authors:  Toni M Antalis; Thomas H Bugge; Qingyu Wu
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  Interleukin 7 from maternal milk crosses the intestinal barrier and modulates T-cell development in offspring.

Authors:  Richard Aspinall; Andrew M Prentice; Pa Tamba Ngom
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

6.  Structure basis for the unique specificity of medaka enteropeptidase light chain.

Authors:  Jin Xu; Shi Hu; Xiaoze Wang; Ziye Zhao; Xinyue Zhang; Hao Wang; Dapeng Zhang; Yajun Guo
Journal:  Protein Cell       Date:  2014-03       Impact factor: 14.870

7.  Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.

Authors:  Nicolas Faller; Ivan Gautschi; Laurent Schild
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.